Press release
Pneumococcal Vaccine Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Pneumococcal Vaccine
What Is the Expected Pneumococcal Vaccine Market Size During the Forecast Period?
Recent years have seen a significant increase in the size of the pneumococcal vaccine market. The market is projected to expand from $8.94 billion in 2024 to $9.49 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. The historic period growth can be credited to factors such as the discovery of streptococcus pneumoniae, public health consciousness, preemptive vaccination drives, progress in healthcare, and revisions in vaccine policies.
The market size for pneumococcal vaccines is anticipated to witness robust expansion in the forthcoming years, reaching a value of $12.12 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. This projected surge during the forecast period can be credited to the evolution of pneumococcal strains, ongoing R&D, prioritized immunizations, wider availability of vaccines, and an aging populace. Notable trends during this forecast period encompass the creation of multivalent vaccines, focusing on vaccination for high-risk groups, enhancing the efficiency of vaccines, emphasizing educational and awareness drives, and targeting vaccination for infants.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11950
What Are the High-Growth Segments in the Pneumococcal Vaccine Market?
The pneumococcal vaccine market covered in this report is segmented -
1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products
2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous
3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels
4) By End User: Pediatrics, Adults
Subsegments:
1) By Prevnar 13: Pediatric Formulation, Adult Formulation
2) By Synflorix: Pediatric Formulation, Adult Formulation
3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes
4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp
What Key Drivers Are Expected to Influence Future Pneumococcal Vaccine Market Growth?
The rise in instances of pneumococcal pollution is anticipated to bolster the expansion of the pneumococcal vaccine market. Pneumococcal pollution encompasses any infection instigated by Streptococcus pneumoniae or pneumococcus bacteria, such as pneumonia, infections in the bloodstream, ear infections, and sinus infections. The pneumococcal vaccine incites the body to manufacture antibodies that counter pneumococcal bacteria, diminishing or eradicating bacteria and toxins that cause disease and safeguarding children, the elderly, and those with compromised immune systems from various pneumococcal infections. For example, as reported by the US-based Center for Disease Control and Prevention in January 2022, it was estimated that Pneumococcal pneumonia led to approximately 150,000 hospitalizations annually in the United States, accounting for up to 30% of adult community-acquired pneumonia. Hence, the growing incidence of pneumococcal pollution is a significant factor propelling the expansion of the pneumococcal vaccine market.
Which Companies Hold the Largest Share Across Different Pneumococcal Vaccine Market Segments?
Major companies operating in the pneumococcal vaccine market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Astellas Pharma Inc., CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, Inventprise LLC, Tergene Biotech Private Limited, PnuVax Incorporated, SK Bioscience Co Ltd
What Trends Are Driving Growth in The Pneumococcal Vaccine Market?
Top-tier companies in the pneumococcal vaccine market are using product innovation to improve their market profit. For example, Merck & Co Inc., a pharmaceutical company from the US, introduced the V116 vaccine in July 2023. The vaccine V116 is designed to target the eight separate serotypes of Streptococcus pneumoniae that are predominantly behind adult pneumococcal diseases. V116 has demonstrated superior immunogenicity against numerous serotypes in adults compared to other pneumococcal vaccines and has also elicited positive immune reactions among individuals both new to and previously exposed to vaccination. The FDA in the U.S. has accorded V116 the status of a breakthrough therapy, and it's currently under Phase 3 development.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report
What Are the Emerging Geographies for The Pneumococcal Vaccine Market Growth?
North America was the largest region in the pneumococcal vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pneumococcal Vaccine Market?
2. What is the CAGR expected in the Pneumococcal Vaccine Market?
3. What Are the Key Innovations Transforming the Pneumococcal Vaccine Industry?
4. Which Region Is Leading the Pneumococcal Vaccine Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccine Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 4000522 • Views: …
More Releases from The Business Research Company
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diamond Market Through 2025?
In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate…
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025?
In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion…
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Professional Street Sweeper Market Size By 2025?
The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)…
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
More Releases for Pneumococcal
Invasive Pneumococcal Disease Market Massive Growth opportunity Ahead
Introduction
Invasive pneumococcal disease (IPD), caused by Streptococcus pneumoniae, remains one of the leading causes of serious illness and death worldwide. Manifesting as meningitis, bacteremia, and severe pneumonia, IPD poses the greatest risk to infants, elderly adults, and immunocompromised patients. Despite progress in immunization, the disease continues to cause a significant global burden, particularly in regions with limited vaccine access.
The Invasive Pneumococcal Disease Market is entering a transformative phase, fueled by…
Key Influencer in the Pneumococcal Vaccine Market 2025: Rising Prevalence Of Pne …
What combination of drivers is leading to accelerated growth in the pneumococcal vaccine market?
The escalating occurrence of pneumococcal infections is projected to boost the pneumococcal vaccine market's growth. Pneumococcal infections represent any condition triggered by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This includes illnesses like pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine encourages the body to generate antibodies against these bacteria, thereby minimizing or…
Pneumococcal Vaccines Market - Preventing Pneumonia: Safeguarding Health with Pn …
Newark, New Castle, USA: The "Pneumococcal Vaccines Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Pneumococcal Vaccines Market: https://www.growthplusreports.com/report/pneumococcal-vaccines-market/7761
This latest report researches the industry structure, sales, revenue,…
Global To Invigorate The Intravenous Pneumococcal Vaccines Market
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine.
The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than two years of age, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. The CDC recommends pneumococcal polysaccharide vaccine for all…
Pneumococcal Vaccines Market Demands and Gross Margin 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry…
Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p …
Latest Survey on Pneumococcal Vaccine Market:
The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It also…
